These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 20549958

  • 1. [Genotype distribution of chronic hepatitis B and hepatitis C patients and investigation of the resistance patterns in hepatitis B cases].
    Kalayci R, Altindiş M, Gülamber G, Demirtürk N, Akcan Y, Demirdal T.
    Mikrobiyol Bul; 2010 Apr; 44(2):237-43. PubMed ID: 20549958
    [Abstract] [Full Text] [Related]

  • 2. Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B.
    Akman SA, Kose S, Halicioglu O.
    Int J Infect Dis; 2010 Mar; 14(3):e236-9. PubMed ID: 19665408
    [Abstract] [Full Text] [Related]

  • 3. Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistance.
    Chen CH, Lee CM, Tung WC, Wang JH, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.
    J Hepatol; 2010 Apr; 52(4):478-85. PubMed ID: 20185198
    [Abstract] [Full Text] [Related]

  • 4. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Mirandola S, Sebastiani G, Rossi C, Velo E, Erne EM, Vario A, Tempesta D, Romualdi C, Campagnolo D, Alberti A.
    Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
    [Abstract] [Full Text] [Related]

  • 5. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
    Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.
    Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
    [Abstract] [Full Text] [Related]

  • 6. [Resistance mutation patterns of hepatitis B virus in patients with suboptimal response to adefovir dipivoxil therapy after lamivudine resistance].
    Wu ZP, Hang T, Gao YT, Li Y, Liu T, Jing L, Liu L, Du Z.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):498-501. PubMed ID: 20678438
    [Abstract] [Full Text] [Related]

  • 7. A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients.
    Idilman R, Kaymakoglu S, Oguz Onder F, Ahishali E, Bektas M, Cinar K, Pinarbasi B, Karayalcin S, Badur S, Cakaloglu Y, Mithat Bozdayi A, Bozkaya H, Okten A, Yurdaydin C.
    J Viral Hepat; 2009 Apr; 16(4):279-85. PubMed ID: 19222742
    [Abstract] [Full Text] [Related]

  • 8. Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome.
    Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, Sabahi F, Zali MR, Luedde T, Trautwein C, Tacke F.
    J Hepatol; 2009 Oct; 51(4):647-54. PubMed ID: 19586679
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
    Lee YS, Chung YH, Kim JA, Kim SE, Shin JW, Kim KM, Lim YS, Park NH, Lee HC, Lee YS, Suh DJ.
    Liver Int; 2009 Apr; 29(4):552-6. PubMed ID: 19323782
    [Abstract] [Full Text] [Related]

  • 10. [The rate of hepatitis B virus resistance to adefovir dipivoxil (ADV) and the evolution of hepatitis B virus in lamivudine-resistant chronic hepatitis B patients with ADV monotherapy].
    Qin YL, Zhang JM, Huang YX, Mao RC, Yin YK, Zhang WQ, Zhang QB, Wu XH, Weng XH.
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):4-7. PubMed ID: 17244449
    [Abstract] [Full Text] [Related]

  • 11. Monitoring of therapy in patients with chronic hepatitis B virus.
    Arrese E, Basaras M, Blanco S, Ruiz P, Cisterna R.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
    [Abstract] [Full Text] [Related]

  • 12. [Clinical analysis of hepatitis B virus mutations related to adefovir dipivoxil among patients with chronic hepatitis B virus infection in eastern Zhejiang province].
    Hu AR, Jiang SW, Li L, Ding SX, Hu YR, Liang XY.
    Zhonghua Yi Xue Za Zhi; 2012 Jul 17; 92(27):1878-81. PubMed ID: 23134956
    [Abstract] [Full Text] [Related]

  • 13. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
    Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.
    J Gastroenterol Hepatol; 2010 Aug 17; 25(8):1374-80. PubMed ID: 20659226
    [Abstract] [Full Text] [Related]

  • 14. Virologic responses to add-on adefovir dipivoxil treatment versus entecavir monotherapy in children with lamivudine-resistant chronic hepatitis B.
    Chu M, Cho SM, Choe BH, Cho MH, Kwon S, Lee WK.
    J Pediatr Gastroenterol Nutr; 2012 Dec 17; 55(6):648-52. PubMed ID: 22688509
    [Abstract] [Full Text] [Related]

  • 15. Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
    Heo NY, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Hepatol; 2010 Sep 17; 53(3):449-54. PubMed ID: 20646776
    [Abstract] [Full Text] [Related]

  • 16. Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
    Buti M, Elefsiniotis I, Jardi R, Vargas V, Rodriguez-Frias F, Schapper M, Bonovas S, Esteban R.
    J Hepatol; 2007 Sep 17; 47(3):366-72. PubMed ID: 17561304
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone.
    Shim JH, Suh DJ, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.
    Hepatology; 2009 Oct 17; 50(4):1064-71. PubMed ID: 19637288
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B.
    Gallego A, Sheldon J, García-Samaniego J, Margall N, Romero M, Hornillos P, Soriano V, Enrĺquez J.
    J Viral Hepat; 2008 May 17; 15(5):392-8. PubMed ID: 18221300
    [Abstract] [Full Text] [Related]

  • 19. [Polymerase region mutations and hepatitis B virus genotypes in chronic hepatitis B patients with poor response to lamivudine].
    Xu LJ, Pan C, Li QG, Chen RH, Zheng L, Zhang QY, Chen HC.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar 17; 18(3):180-3. PubMed ID: 20380793
    [Abstract] [Full Text] [Related]

  • 20. Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia.
    Svicher V, Alteri C, Gori C, Salpini R, Marcuccilli F, Bertoli A, Longo R, Bernassola M, Gallinaro V, Romano S, Visca M, Ursitti A, Feasi M, Micheli V, Angelico M, Cassola G, Parruti G, Gubertini G, De Sanctis GM, Ceccherini-Silberstein F, Cappiello G, Spanò A, Perno CF.
    Dig Liver Dis; 2010 Dec 17; 42(12):902-7. PubMed ID: 20621632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.